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Abstract 
 
Introduction 
The bulk of the surgical literature about laryngeal cancer is concerned with cure 
rates or five-year survival rates. While this is important, the five year survival rate  
is only one measure of success of laryngeal cancer surgery. Whereas, 
postoperative morbidity and mortality are also very important.  
 
Pharyngocutaneous fistula (PCF) is the most frequent complication in the early 
post operative period after total laryngectomy. It creates a communication 
between the pharynx and the cervical skin or less frequently with the stoma of 
the tracheostomy. The pharyngeal contents, usually saliva, flow through the 
fistula emerging from the cutaneous orifice. 
 
This study aims to determine the incidence and the predisposing factors for the 
development of pharyngocutaneous fistula (PCF); and to review the 
management and outcome of such cases following total laryngectomy at Ear, 
Nose and Throat (ENT) department, Chris Hani Baragwanath Hospital.  
 
Patients and methods 
This is a retrospective study. The medical records of 30 patients who underwent 
total laryngectomy surgery for squamous cell carcinoma of the larynx with no 
local neck metastases between June 2000 and May 2008 were assessed. 
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All patients had similar (standard) preoperative and post operative care. I studied 
a number of factors that could influence pharyngocutaneous fistula formation 
such as age, smoking habit, alcohol consumption, tumour stage, preoperative 
tracheostomy, preoperative hemoglobin and associated systemic diseases 
(gastroesophageal reflux, chronic obstructive pulmonary  disease, systemic high 
blood pressure and diabetes mellitus)  
 
Results 
 Pharyngocutaneous fistula appeared in 20% (6/30 patients). Spontaneous 
closure with local wound care was noted in 5 patients (83.3%), whereas a 
surgical closure was necessary in one patient .  
 
Conclusion  
The results of our study concluded  that pharyngocutaneous fistula remains a 
troublesome complication of the early post-operative period after total 
laryngectomy. There are many conflicting reports in the literature concerning the 
pharyngoctaneuos fistula  predisposing factors, but our study  data (table 1 page 
22) of age, smoking habit, alcohol consumption, tumor stage, preoperative 
tracheostomy, preoperative hemoglobin and associated systemic diseases( 
gastroesophageal reflux, chronic pulmonary obstructive disease, systemic high 
blood pressure and diabetes mellitus) did not show  any significant value. 
Our experience confirmed that most pharyngocutaneous fistulas can be 
successfully treated conservatively. 
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Introduction 
 
A fistula is an abnormal communication between two epithelialized surfaces. In a 
pharyngo-cutaneous fistula the communication occurs between the pharyngeal 
mucosa and the skin of the neck due to failure in pharyngeal healing.  This 
results in a salivary leak. 
 
This is a devastating complication not only for the surgical management involved 
but also for the patient and his family. Its occurrence leads to increased 
morbidity, delay in adjuvant treatment, prolonged hospitalization and increased 
treatment costs 5. 
 
Anatomy of the larynx 
 
The larynx is located at the upper part of the air passage (Fig 1). It is situated 
between the trachea and the root of the tongue; at the upper and forepart of the 
neck; where it presents a considerable projection in the mid-line. It forms the 
lower part of the anterior wall of the pharynx and is covered behind by the 
mucous lining of that cavity.  On either side of it lie the great vessels of the neck. 
Its vertical extent corresponds to the fourth, fifth and sixth cervical vertebrae, but 
it is placed somewhat higher in females and in children.   
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                 Fig 1: Location of the larynx                                      
 Copyright© 1999 by Wesley Norman, PhD, Ds c(home.comcast.net) 
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The skeleton of the larynx consists of nine cartilages (Fig. 2) - three  single and 
three paired -   
 
          Thyroid                                                                            2  Arytenoids                                     
          Cricoid                                                                             2  Corniculate 
          Epiglottis                                                                          2   Cuneiform 
  
 
                       Fig 2: The laryngeal skeleton 
         (Copyright© Henry Gray (1825–1861).  Anatomy of the Human Body.1918) 
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Laryngeal embryology  
 
The larynx develops from the fourth and fifth branchial arches. At the third week 
of gestation, the respiratory primordium is derived from the primitive foregut to 
later form the lung bud and later the bronchial bud which will eventually develop 
into the tracheo-bronchial tree. At the fourth and fifth week of gestation the 
tracheo-oesophageal folds fuse to form the tracheo-oesophageal septum leading 
to the separation of the tracheal airway lumen from the esophageal digestive 
tract. 
 
The laryngotracheal groove is the primitive opening of the larynx during 
development. This structure will develop into the primitive laryngeal aditus which 
are formed by three eminences. The hypobranchial eminence is the most 
cephalad of the structures and will later develop into the epiglottis. The other two 
eminences will form the arytenoid cartilages. The laryngeal lumen obliterates and 
later recanalizes by the tenth week of gestation. 
 
Laryngeal function    
The larynx has an array of functions including -  
 Breathing passage 
 Airway protection 
 Clearance of secretion 
 Vocalization 
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Reduction in the size of the laryngeal airway can produce symptoms of airway 
obstruction ranging from mild stridor, to increased work of breathing presenting 
with chest wall retraction, nasal flaring, tachypnea, apnea, cyanosis and even 
sudden death. 
 
Laryngeal cancer 
Laryngeal cancer is a serious disease. It is typically a disease of elderly smoking 
men. Even though laryngeal cancer is the most common head and neck 
malignancy, it comprises approximately only 1% of all malignancies1 and 30 - 
50% of head and neck carcinomas 2. 
 
The overall prognosis of laryngeal squamous cell carcinoma (LSCC) is relatively 
good compared to head and neck cancers in general. However, the treatment 
options available, especially those for advanced disease cause severe 
impairment of the quality of life. This warrants a search for more conservative, 
yet equally effective treatment regimens. Further, methods for detecting these 
cancers at an earlier stage and for distinguishing the cancers with more 
aggressive behavior are being sought. . These are the cancers that have 
potentially the  worst prognosis. Despite the general improvement in cancer care 
during the past decades, the survival of LSCC has not improved significantly 1, 2. 
 
In spite of a multitude of published studies, our knowledge about the prognostic 
factors of LSCC has not markedly increased during the past decades 1, 2. Even 
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today, the disease stage at the time of diagnosis and the anatomical subsite of 
the tumour are the only solid and practical prognostic factors and tools in 
choosing the treatment protocol for laryngeal squamous cell carcinoma (LSCC). 
A wide variety of histopathological factors have been studied as potential 
indicators of poor prognosis and, consequently, aggressive treatment, but with 
conflicting results 1, 2. 
   
Many  options  are  available  for  treatment  of  laryngeal cancer  which  include  
laser surgery 1 ,  partial laryngectomy, radiation therapy, chemotherapy and  total 
laryngectomy.  Frequently patients undergo total laryngectomy after unsuccessful 
attempts at preserving the larynx with partial laryngectomy 3, failed radiation 
therapy or for advanced laryngeal cancer. 
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 Review of literature 
 
History of pharyngo-cutaneous fistula (PCF) 
Total laryngectomy started in 1829 by Dr Albers who recorded successful 
extirpation of the larynx of a dog which lived for 9 days 4. 
 
Billroth performed what is considered to be the first successful total laryngectomy 
on a human being in 1973. The patient was a 36 year old man who was thought 
to have a tumor on one vocal cord which was excised. Nine days later the entire 
larynx had to be removed because the growth had spread and infection 
developed. The patient died from local recurrence of the tumor in the neck, which 
included a worsening PCF. 
 
Billroth was also the first person to report PCF as one of the complications of 
total laryngectomy 4.  
 
 The procedure of total laryngectomy is still followed by surgical  complications  
which may cause serious morbidity and even mortality such as severe  infection 
with flap  necrosis  resulting  in carotid blow out; or the development  of  PCF 
which is the most common complication. 
 
Incidence of pharyngo-cutaneous fistula 
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The reported incidence of PCF in international literature, is extremely variable 
ranging from 3.6% to 65% 6,7,19,2. 
 
Attributing factors of pharyngo-cutaneous fistula 
Despite a large number of studies performed to find out the contributing factors in 
the development of PCF with the aim of reducing its incidence, there is still 
disagreement on factors that predispose to this complication. 
 
Various contributing factors have been identified, including:- 
 
a) Time of oral feeding 
It is surprising what little information is available in the literature to support the 
time of initiation of the oral feeding. It is well known that a skin incision heals 
in a water tight fashion within 24 - 48h after surgery 7.  It seems reasonable to 
assume that the pharyngeal mucosa could do the same in a similar period. 
Under normal conditions saliva is swallowed at a rate of 1500 ml/24hours. 
Saliva is as potentially harmful mechanically as other swallowed liquids or soft 
food.  
 
Initiating oral feeding within 48 hours of total laryngectomy without partial 
pharyngectomy; who have not had a previous surgical resection of the upper 
aerodigestive tract; and who have either not received previous therapeutic 
 8
irradiation to the head and neck region; does not increase the frequency of  
PCF 7.  
Oral feeding especially with solid food encourages granulation tissue 
formation along the fistula tract and eventually results in more spontaneous 
closure of the fistula tract 8. 
    
b) Gastroesophageal reflux disease(GORD)  
Gastroesophageal reflux disease has recently been identified as an important 
factor in numerous inflammatory and neoplastic disorders of the upper 
aerodigestive tract.  It is associated with contact ulcers and granulomas of the 
larynx, chronic laryngitis, post intubation laryngeal complications, laryngeal 
stenosis and even laryngeal cancers especially in non-smokers. 
 
Seventy one percent of patients with laryngeal carcinoma had abnormal 24-
hour pH studies using the double pH probe monitoring system9.  This 
suggests that many patients undergoing laryngectomy also have 
gastroesophageal reflux. Prophylactic use of ranitidine (H2 receptor blocker) 
and metoclopramide (prokinetic) has decreased the incidence of pharyngo-
cutaneous fistula and the mean length of hospital stay after total  
laryngectomy 10 . 
 
c) Age 
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Age has received increasing attention as a prospective factor for post 
operative complications. The suitability of surgical candidates based on 
chronological age has been a source of controversy.  Traditionally, 
patients more than 60 years of age are predisposed to wound related 
complications including PCF formation 11. 
 
d) Preoperative tracheostomy 
Tracheostomy is frequently performed for more advanced tumors.  These 
are usually due to airway obstruction at presentation. In emergency 
situations this is usually performed in a bacterially contaminated field; and 
this may contribute to post total laryngectomy PCF fistula formation 12.     
 
e) Tumor stage and laryngeal site 
The size of the primary tumor has no effect on PCF formation, although 
supraglottic tumors have significantly more fistulas than glottic tumors 13. 
They attributed this to extension of supraglottic tumors either to the 
vallecula or to the pyriform fossa, consequently requiring excision of large 
part of pharyngeal mucosa which resulted in closure being performed 
under some  tension. 
 
f) Preoperative Hemoglobin 
 Low preoperative hemoglobin increases the incidence of PCF nine-fold 14. 
This rise in the number is related simply to a decrease of the oxygen 
 10
carriage to the repair site by the heamoglobin poor blood, thus 
predisposing to poor wound healing. 
 
g) Preoperative  radiation 
It  is  well  known  that  irradiated  tissue  lacks   good  tissue circulation, is  
friable and must  be  handled  more  gently  than  non-irradiated  tissue. In 
the acute phase; during the delivery of radiotherapy; cells that regularly or 
rapidly divided are killed leading to acute toxic effects such as dermatitis 
or mucositis. The second, or chronic, phase of radiotherapy injury results 
from the effects  of  irradiation  on  native  tissue  are   endarteritis  
obliterans,  excessive  fibrosis, decrease of cellular  replication  and  
disruption  of  wound  healing  by  tissue  ischemia  and  impaired  
angiogenesis.  
 
An increase in the number of PCF is related to the increase of the 
radiation field size, dose increment and a change from continuous to 
fractionated radiation therapy 15.        
  
h) Malnutrition 
The incidence of malnutrition has been reported in the literature between 
30% to 50% in patients with head and neck cancers. Patients with  more  
than  10%  weight  loss in the  6 months  prior  to  surgery  were  at 
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greatest risk  for  the  development of  major  post-operative  
complications 17. 
 
i) suture material 
There is a statistically significant difference in the formation of PCF 
between vicryl  and  catgut  groups  in favor of  vicryl  which  has greater 
tensile strength,  less inflammatory reaction and  has a longer  half-life 18 . 
 
j) Positive surgical  margins 
Presence  of  infiltrated  margins  may  explain  the  higher  frequency  of  
fistula formation as a result  of  deficient healing process  occurring at  the  
surgical wound, where  the  presence  of  the  tumor cells may  negatively  
influence the healing process and wound closure 19. 
 
k) Vascular diseases related to smoking and alcohol drinking 
This may play a huge role especially if there is clinical evidence of 
vascular disease. Various mechanisms may explain this association. 
Nicotine-induced vasoconstriction leads to limited perfusion and, together 
with carbon monoxide-induced cellular hypoxia, results in decreased 
tissue oxygen tension causing reduction in collagen deposition and tensile 
strength in the wound 30.  
 
Detection of pharyngo-cutaneous fistula 
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This can be accomplished by careful post-operative monitoring of: 
    
       i)  Temperature. 
 Fever in the early post operative period (first 48 hours) particularly when 
corrected for atelectasis and pneumonia is an excellent predictor of a 
fistula formation. Fistula  developed  in  71%  of   the patients  with  early  
post-operative  fever >101.5 F (38.6 Ċ) compared with only 4% of those 
without fever  20 . 
 
ii)    Wound amylase concentration 
Amylase is an enzyme present in small amounts in the serum (500 IU/λ) 
and in the saliva (70.000 IU/λ). Drain amylase >4000 IU/λ on day one post 
total laryngectomy   is a predictor of PCF development 21.  
 
         iii)    Radiologic assessment 
 A barium-swallow videoesophageogram is indicated in patients with signs 
and symptoms suggestive of an impending fistula (fever, wound erythema, 
wound swelling, or persistent elevated neck-drain output) to be an 
excellent predictor of a clinical fistula 22. 
 
Management of pharyngo-cutaneous fistula 
The  management  of  PCF  is  a challenge   for  the  surgeon  and the  patient  
alike. Options are as follows: 
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 1. Conservative treatment 
    The conservative treatment of the PCF aims to preserve and restore the 
injured region. It is a complex, dynamic and systemic process, depending on the 
general health condition of the patient, and can be delayed by several intrinsic 
factors (age, preexisting medical diseases, radiotherapy, poor nutrition, low 
hemoglobin) which should be identified in order to promote the continuity of the 
treatment process 11, 12,13. 
 
Early recognition of a fistula can prevent secondary wound complications and 
reduce the incidence of catastrophic complications. Areas suspicious for fluid 
collection should be aspirated and if purulence or salivary contamination is 
detected, exteriorization should be done immediately by opening the suture lines. 
The drainage will divert the fistula from critical structures such as the carotid 
sheath and posterior tracheal wall 20.   
 
Temporary techniques can be used. 
 
a)  Silicon septal button is described as a temporary management of selected 
PCF which are not more than 1cm in size and the cases cannot be repaired in a  
reasonable period of time.  There is however two limiting factors related to the 
use of this technique 23  
• High cost of the button 
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• Prevents spontaneous closure 
Other potential complications include erosion of surrounding tissue and  
aspiration of  the  button  if  it is too small for the fistula opening. 
 
b)   Decrease salivation by injection of Botulinum Toxin (BTX) 
Injecting BXT into the parotid and submandibular glands, if not resected with 
neck dissection, in both sides under ultrasonographic guidance was used in  
three  patients with  PCF gave good results 24.  
 
2. Surgical management  
Several articles in the literature described techniques that are used for surgical 
closure of the PCF. The wide variety of reconstructive procedures described 
indicates the lack of a single, reliable operative approach that can be used in all 
cases. This is due to the great differences in PCF presentation. However, the 
principle of PCF fistula closure is the same in all cases and relies on the simple 
fact that a fistula must be closed by two epithelial surfaces, one to provide an 
internal lining and the second for external cover. 
 
PCF have been classified according to source of tissue used in reconstruction to 
three types 28.    
• Type 1 fistula is that where both tissue surfaces can be provided locally. 
• Type 2 fistula, one tissue surface can be provided locally and the other 
must be provided from a distance. 
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• Type 3 fistula, is a fistula that requires both surfaces from distance. 
 
Surgical  management  is  indicated  in  cases  where  conservative  
management  fails and  fistula  persists, exposing  the  patient  to  continuous  
salivary  leak  with  inherent risks  of  infection, aspiration, carotid  artery  
exposure  and  even  rupture.     
 
The  timing  of  surgical  repair of  a fistula  is not  clear in  the  literature, some 
suggested forty post-operative  days 25. Many options are available for 
reconstruction of PCF fistula which includes: 
 
i) Primary closure 
Primary closure of  PCF is rarely possible but may be considered in small  fistula 
in  cases in which there is minimal surrounding  soft  tissue  loss  and  the 
mucosa seems  healthy  and  adequate  for  closure.  
 
1. Loco-regional  flaps 
• Myocutaneous  flaps 
The  pectoralis major  flap  offers  the  benefit  of  an  excellent  
vascular  pedicle. The  latissimus  dorsi  and  the  trapezius  flaps  
represent  available  myocutaneous  flaps  with overlying skin fed by 
musculocutaneous perforating vessels. These  flaps  have  been  used  
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for  oesophageopharyngeal  reconstruction, but are  much  less  
advantageous  than  the  versatile, durable  pectoralis  major. 
 
• Muscle  flaps 
 Sternocleidomastoid muscle flap is also used for fistula closure which 
has advantages of workable mass, good coverage and single stage 
reconstruction.  
 
2. Free flaps 
• Radial  forearm free  flap  in  conjunction  with  the  Montgomery  salivary 
bypass  tube   revealed good results for reconstruction  of  defects of the 
hypopharynx and cervical oesophagus 26 . The Montgomery bypass tube 
stents the reconstruction and decreases the exposure of the anastomotic  
suture  line to saliva. 
 
• Dorsalis pedis flap is a suitable choice in the management of large 
pharyngocutaneous fistula 31. Because the transferred tissue in this area is 
preferred to be adequately pliable and thin which affects the aesthetic and 
functional outcomes. On the other hand it leaves relatively less 
conspicuous scar on the foot which may better accepted by the patients 
because of its’ less noticeable location. 
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Rationale for the Study 
The information of this study will define and identify patients at risk for developing 
PCF post-total laryngectomy and assist in their management. 
 
Aim 
The overall aim of this study is to assess the current status of pharyngo-
cutaneous fistula after total laryngectomy at the Department of Otolaryngology, 
Head and Neck Surgery, Chris Hani Baragwanath Hospital.  
 
Specific Objectives 
 
1. To describe the patients treated with total laryngectomy for carcinoma of 
the larynx with no local metastasis in the department. 
2. To determine the incidence of pharyngo-cutaneous fistula post total 
laryngectomy. 
3. To assess predisposing factors related to developing pharyngo-cutaneous 
fistula.  
4. To evaluate the management and outcome of pharyngo-cutaneous fistula 
in this institution. 
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Methods 
 
Ethics approval 
This study was approved by the standards and ethics Committee of the 
University of the Witwatersrand (Ethics clearance number  M090221). 
 
Study setting 
This retrospective study was conducted at the Otorhinolaryngology Department, 
at the chris Hani Baragwanath Hospital, which is an academic department 
affiliated to the University of the Witwatersrand. It is a tertiary referral center for 
patients suffering from ENT diseases. 
 
Study population 
The study includes all patients who underwent a total laryngectomy as part of 
their management for carcinoma of the larynx with no regional metastases. 
 
Inclusion and exclusion criteria:  All total laryngectomy patients that fulfilled the 
inclusion criteria of having a histologically-proven carcinoma with no local 
metastasis were included. The study excluded all patients who underwent total 
laryngectomy with additional surgical procedure like radical or functional neck 
dissection, partial laryngectomy and failed radiation therapy. 
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 Study period 
Data for the study was collected on all patients seen between June 2000 and  
May 2008. 
 
Data collection 
A list of all the names and numbers of the patients who met the inclusion criteria 
was obtained from the theatre records. The medical files were then recieved and 
each  file was studied. 
 
A data collection sheet was utilized for the purpose of extracting information from 
patient records (see Appendix A page 38). The following variables were 
extracted from the notes and transferred to the data sheet: 
 
• Age 
• Smoking  habit 
• Alcohol  
• Pathologic  primary  tumor  staging  according  to  TNM  classification   
• Concurrent medical problems (COPD, Diabetes Mellitus, systemic blood  
hypertension, gastroesophageal  reflux) 
• Pre-operative tracheostomy 
• Pre-operative hemoglobin 
 
Data analysis and presentation 
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Statistical analysis included assessment of central trend and dispersion; absolute  
and relative frequencies; and Fisher's exact test to verify association between all  
categorical variables and the development of fistula. A probability (p) value of 
more than 0.05 is regarded as insignificant. 
 
The following software applications were used manipulation, statistical analysis 
and presentation. 
 
 Microsoft Access 2003 Database for data storage, retrieval and selection. 
 Microsoft Excel 2003 spreadsheet for descriptive data analysis, summary 
statistics and comparison of sample means. 
 SATA version 10 for analytical testing. 
 
Results. 
30 patients were identified from the registers of the operating theatre and ENT 
ward as patients who had undergone total laryngectomy surgery. 
 
Incidence of PCF 
Six of the thirty patients who underwent total laryngectomy developed a 
pharyngocutaneous fistula during the post-operative period achieved an 
incidence rate of 20%. The time of appearance of the pharyngocutaneous fistula 
varied between 3 and 10 days, mean 7.16 ± 3.25 days.  
The vast majority of the fistulae (50%) were observed by 10th postoperative day. 
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Various factors were assessed to determine predisposing factors for developing  
PCF (Table 1). 
 
 
 
Table 1 Distribution of patients with pharyngo-cutaneous fistula 
                Pharyngo-cutaneous fistula %               Variables 
 No fistula (24) 
n (%) 
Fistula  (6) 
n (%) 
 
p value 
Age (mean±SD) years 56.5±10.2 59±11.4 0.60 
Age                 
< 60 years 
≥ 60 years 
 
16 (66.7%) 
8 (33.3%) 
 
3 (50%) 
3 (50%) 
 
0.64 
 
Smoking          22 (91.7%) 5 (83.3%) 0.50 
Alcohol              20 (83.3%) 5 (83.3%) 1.0 
Tumor Stage    
T2 
T3 
T4 
 
1 (4.2%) 
11 (45.8%) 
12 (50%) 
 
0 
1 (16.7%) 
5 (83.3%) 
 
0.48 
Tracheostomy   3 (12.5%) 2 (33.3%) 0.25 
Preoperative Hb 
(mean±SD) gm/dl 
13.6±2.0 13.4±1.6 0.78 
Preoperative Hb                
≤ 11.5 mg/dl 
> 11.5 mg/dl 
 
4 (16.7%) 
20 (83.3%) 
 
1 (16.7%) 
5 (83.3%) 
 
0.25 
 
GORD         1 (4.2%) 0 1 
HT            6(25%) 1(16.7%) 1 
DM           2 (8.3%) 0 1 
COPD        1 (4.2%) 1 (16.7%) 0.27 
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Age 
 The mean value of the age in both groups, fistula 59 years and no fistula, was 
slightly  different 2.5 years  and the  two groups were comparable (Fig 3). 
                                                                                     
55
56
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Fistula No fistula
ag
e/
ye
ar
Series1
      
                    Fig 3: Patients mean age                               
 
The rate of development of a postoperative PCF according to the age groups of 
≤60 and >60 years did not differ in a statistically significant manner and is 
demonstrated in table 1 page 22. 
 
Smoking and alcohol habit 
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Majority of the patients were smokers and alcohol consumers (90% and 83.33%)  
respectively. PCF developed in only five patients in each group with no 
significant value recorded.   
 
Tumor stage  
These seems to be a greater observed tendency for pharyngocutaneous fistula 
development in relation to T4 suprglottic tumors, probably because more 
pharyngeal mucosa is excised as part of tumor margin.   
 
Preoperative tracheostomy 
Only 5 of 30 patients (16.66%) underwent emergency tracheostomy for the 
airway distress before the planned total laryngectomy, which did not show any 
significant value for developing PCF. 
 
Preoperative hemoglobin 
PCF developed more frequently in patients with hemoglobin value of > 11.5 
gm/dl (83.33%), which revealed that low hemoglobin value < 11.5 gm/dl 
insignificant factor for developing PCF. 
 
Medical associated conditions 
In this study group, PCF occurred in one patient with systemic high blood 
pressure (14.28%), one patient with chronic obstructive disease (50%), while no 
fistula among the diabetes mellitus and the gastroesophageal reflux disease 
 24
patients. In this study no significant association noted with any pre-existing 
comorbidity and the development of PCF.  
Description of total laryngectomy approach 
All patients were meticulously prepared as for any major surgical procedures, 
including a thorough head and neck examination, preoperative endoscopic 
examination of upper respiratory and alimentary tracts, evaluation of all 
necessary hematological and biochemical values, radiographs of chest and neck 
with use of computed tomography or magnetic resonance imaging studies as 
needed. TNM classification was used according to American joint committee for 
staging of the tumor. 
 
All surgical procedures were carried out by different surgeons with same 
technique. All of the patients received preoperative Augmentin 1.2gm. A 
transverse collar incision was used approximately two fingers breadth above the 
sternal notch extended, superiorly and laterally on both sides, anterior to the 
anterior border of the sternoclidomastoid muscle just above the hyoid bone.  
A standard total laryngectomy was performed including the hyoid bone, isthmus, 
and lobe of the thyroid gland on the tumor side. 
 
After removal of the specimen 15 patients received Nasogastic tube(NGT), while 
the other 15 patients received tracheo-esophageal puncture(TEP) by placing a 
right angled hemostat against the back of the trachea through the esophagus 
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and a horizontal incision was made over the hemostat 1-1.5 cm below the 
tracheal edge . 
 
A size 16 french Foley's silicone lined catheter was inserted through the puncture 
site towards the stomach and secured by adhesive plaster. The pharyngeal 
mucosal defect then was repaired meticulously with vicryl absorbable sutures. 
The pharyngeal muscle was closed as a second layer. The closure was in a 
straight or T-fashion, whichever closure had the least tension.  
 
Suction drains were used in all the patients; and removed when the drainage was 
less than 50 ml/day. No post-operative antibiotics were given unless the patient 
developed  wound infection or any other infection requiring antibiotics. 
 
All the patients were fed through the nasogastric tube (NGT) or the tracheo-
esophageal puncture  tube (TEP) for 7-10 days where routine barium swallow 
screen was done, if  the  swallow screen was negative i.e no pharyngeal leak, 
then oral feeding with clear fluids  was started orally and gradually changed to 
normal food. 
 
A standard criteria for discharging patients was followed.  This includes that   
suction drains have been removed, that the patient has returned to a normal oral  
diet  and that post operative recovery, which is defined as patient not requiring 
hospital care and having no need for intravenous medications is achieved. 
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 In the patients who developed PCF, consideration was given to the post 
operative day on which it was diagnosed, its duration, the period of 
hospitalization, therapeutic approach and outcome. 
 
Management and outcome  
In this study, spontaneous PCF closure was achieved in five of the six patients          
( 83.3%) within a month time in  whom treated conservatively by instructing the 
patient not to swallow the saliva and to frequently use the oral suction, keeping 
the patient nothing per os (NPO), enteral feeding through the nasogastric tube 
(NGT) or through the tracheoesophageal puncture (TEP) which was already 
inserted intraoperatively, twice daily wound dressing with iodine and intravenous 
antibiotics injection. 
 
The sixth patient in the series failed to respond to the conservative treatment for 
a month, after which he was taken to theatre, the PCF was identified, the mucosa 
debrided and a free fat graft from the subcutaneous tissue of the left lower 
abdomen inserted in to the pouch between the fistula and the neck skin. A 
barium swallow x-ray on the tenth post operative day revealed that the fistula 
was still leaking. Conservative management continued for further two months 
with serial barium swallow x-rays till the fistula had healed spontaneously.  
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The mean hospitalization days among the PCF patients was 36.5 compared with 
19.5  among the patients who did not have fistula (Fig 5). 
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                                   Fig 4:  Mean hospital stay 
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 Discussion 
 
Over the last century a great deal of research has been carried out to determine 
the causes and the most efficacious treatment of post-total laryngectomy PCF. 
The aim of this project was to assess the current status of pharyngo-cutaneous 
fistula after total laryngectomy at the Department of Otolaryngology, Head and 
Neck Surgery at Chris Hani Baragwanath Hospital.  
 
After total laryngectomy, the occurrence of PCF results in a delayed outcome 
and rarely in carotid artery rupture15. Generally PCF develops just above the 
tracheostoma, at the weakest point of the suture line of the pharyngeal mucosa.  
It is always associated with surrounding tissue necrosis.  It may also occur high 
in the neck, at the level of the junction of the base of tongue and the pharyngeal 
mucosa. 
 
The presence of saliva results in contiguous tissue infection and microvascular 
thrombosis with progressive tissue loss. The overlying skin becomes tender and 
dark red in color. 
 
The incidence of PCF after total laryngectomy is variable in the literature and 
ranges between 3.6% and 65% 6,7,19,25, with an average time of appearance of 10 
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days after surgery. In this study PCF was diagnosed in 6 of 30 patients, 
achieving an incidence of 20%, which is within the range as mentioned in the 
literature 6,7,19,25 . 
   
The occurrence of PCF was diagnosed on the 3rd to 10th day after the operation 
with mean of 7.16±3.25 days; and lasted from 18 to 70 days, which is consistent 
with the mean values as reported in the literature11,14 .  
 
 Statistical analysis in a previous study showed a significant correlation between 
post-total laryngectomy PCF and advanced age11. However the results of this 
study show no correlation between increasing age and the development of PCF; 
where most of the fistulas developed in patients’ of <60 years of age.  This 
sentiment is echoed in other studies 8,19.   
 
Life style factors such as smoking and alcohol consumption are significantly 
associated with blood vessel diseases and wound healing delay27. Although 
majority of the patients in my study were smokers and alcohol consumers, there 
was no relationship between these factors and PCF occurrence.  
 
It is reported that there is a significant increase in the rate of PCF formation in 
large cancers (stage IV versus stage III)18,29, which requires resection of part of 
the pharyngeal mucosa. This however was not found in this study. 
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Preoperative tracheostomy according to one study12, could lead to an increase in 
fistula formation. This is probably due to surgical field contamination with 
bacteria; and the higher tumor stage. This study recorded five patients that had a 
preoperative tracheostomy, which did not seem to be statistically associated with 
fistula formation.  
  
Low preoperative hemoglobin value in this study was not significantly associated 
with formation of PCF which confirms the results of the previous studies 10. Other 
study has found significant rise in the number of PCF in patients with hemoglobin 
values less than 11.5 gm / dl 12. 
 
Associated medical conditions such as systemic high blood pressure, diabetes 
mellitus (DM), gastroesophageal reflux disease (GORD) and chronic obstructive 
pulmonary disease (COPD) did not seem to have significant values in formation 
of PCF. 
 
Even though much controversy still surrounds the occurrence of PCF, it is 
generally agreed that most fistulas respond well to conservative treatment.  This 
has been reported in 60% to 86% of cases13,16. 
 
According to our study and the literature review13,16, we concluded that 
observation period for one month after the primary surgical procedure is the best 
approach for the PCF.    
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  Conclusion   
This study revealed that the incidence of PCF in patients undergoing total 
laryngectomy for laryngeal cancer is 20%.  This is in keeping with the 
internationally reported incidence6,7,19,25. This study further reaffirmed that PCF 
remains a troublesome complication in the early post-operative period after total 
laryngectomy. 
 
In the presence of specific risk factors as mentioned in the literature7,8,9,11,1214,15,17  
PCF can be expected.  Nevertheless its prevention remains very difficult.  
 
In this study factors of age, smoking, tumor stage, preoperative tracheostomy, 
preoperative hemoglobin and comorbidities such as (gastroesophageal disease, 
diabetes mellitus, systemic high blood pressure and chronic obstructive 
pulmonary disease) did not show any correlation with the occurrence of the PCF 
after total laryngectomy.   
 
(NB ; This study did not have any patients with a positive HIV result)  
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                                                    Appendix  A 
   
 
Patient 
       
   Age 
 
Smoking 
History 
 
 
 
Alcohol 
History 
 
 
 
Stage   
of 
Tumor 
 
 
 
Previous 
Tracheostomy 
 
Preoperative 
Hemoglobin 
gm/dl 
 
GORD 
 
 
 
HT 
 
DM 
 
 
 
COPD 
1           
2           
3           
4           
5           
6           
7           
8           
9           
10           
11           
12           
13           
14           
15           
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29           
30           
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